885519-33-5 Usage
General Description
4-Iodo-6-indazolecarboxylic acid methyl ester is a chemical compound with the molecular formula C10H8IN3O2. It is a methyl ester derivative of 4-iodo-6-indazolecarboxylic acid, and it is commonly used as an intermediate in the synthesis of various pharmaceutical compounds. 4-IODO-6-INDAZOLECARBOXYLIC ACID METHYL ESTER has potential applications in medicinal chemistry and drug development due to its ability to modify the biological activity of certain molecules. It is important to handle 4-iodo-6-indazolecarboxylic acid methyl ester with care, as it may pose health and safety hazards if not used properly. Overall, this chemical has important synthetic and pharmacological applications, making it a valuable compound in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 885519-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,5,1 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885519-33:
(8*8)+(7*8)+(6*5)+(5*5)+(4*1)+(3*9)+(2*3)+(1*3)=215
215 % 10 = 5
So 885519-33-5 is a valid CAS Registry Number.
885519-33-5Relevant articles and documents
NOVEL RENIN INHIBITOR
-
, (2015/09/22)
The present invention provides a nitrogen-containing saturated heterocyclic compound of the formula [I] which is useful as a renin inhibitor. wherein R1 is a cycloalkyl group or an alkyl, R22 is an optionally substituted aryl and the like, R is a lower alkyl group, R3, R4, R5 and R6 are the same or different, and are a hydrogen atom, an optionally substituted carbamoyl, an optionally substituted alkyl, or alkoxycarbonyl, or a pharmaceutically acceptable salt thereof.
INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS
-
Page/Page column 20-21, (2010/12/31)
Compounds of the formula I: or a pharmaceutically acceptable salt thereof, wherein, X, Y, Z, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of using the compounds for treating diseases associated with P2X3 and/or a P2X2/3 receptor antagonists and methods of making the compounds.
